Blogs about: Athersys
Featured Blog
The Developing Embyronic Stem Cell Clinical Landscape
According to an article on CNN.com, Geron’s CEO, Dr. Tom Okarma, confirmed timelines for Geron to initiate human clinical trials with their embryonic stem (ES) cell-based treatment for spinal co… more →
The Regeneration Station
Monday Biotech Deal Review: December 21, 2009
— 1 comment
wrote 2 weeks ago: This week’s deal review shows no signs of a holiday showdown. In Canada, BioMS’ deal wi … more →
PFIZER BUYS INTO ADULT/REPAIR STEM CELL COMPANY ATHERSYS
wrote 2 weeks ago: PFIZER BUYS STEM CELL COMPANY ATHERSYS & Acquires Stem-Cell Therapy Product MulitStem By ANDREW … more →
The Developing Embyronic Stem Cell Clinical Landscape
wrote 1 year ago: According to an article on CNN.com, Geron’s CEO, Dr. Tom Okarma, confirmed timelines for Geron … more →
Athersys’ Adult Stem Cell Product IND Approved for Acute MI Phase I Trial
wrote 2 years ago: Athersys and their cardiac parter, Angiotech, announced today that they got the ok from the FDA to b … more →
Athersys’ adult allogeneic stem cell IND gets OK from FDA
— 1 comment
wrote 2 years ago: On November 15, 2007, Athersys announced in a press release that they had received a letter from the … more →
